1. A10.04 7WISP1, a downstream mediator of canonical wnt signalling, induces pathology in experimental osteoarthritis and predicts disease progression in early osteoarthritis patients. (24th February 2016) Authors: van den Bosch, MH; Blom, AB; Maeda, A; Kilts, TM; van den Berg, WB; Lafeber, FP; van Lent, PL; Young, MF; van der Kraan, PM Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 1 Page Start: A74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0061 35sulphate incorporation assay as a new tool for measuring early cartilage degradation following blood exposure in vitro and in vivo in f8 ko rats. (15th June 2017) Authors: Pulles, AE; Christensen, KR; Coeleveld, K; Kjelgaard-Hansen, M; Schutgens, RE; Lafeber, FP; Roepstorff, K; Mastbergen, SC Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1068 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0818 Personalized articulating joint distraction for treatment of tibiofemoral osteoarthritis: clinical feasibility. (15th June 2017) Authors: Struik, T; Custers, RJ; Besselink, NJ; Jaspers, JE; Marijnissen, AK; Lafeber, FP; Mastbergen, SC Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0008 Effects of the human il4-10 fusion protein in the canine groove model of osteoarthritis. (15th June 2017) Authors: Helvoort, EM Van; Popov-Celeketic, J; Coeleveld, K; Tryfonidou, MA; Lafeber, FP; Mastbergen, SC Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 482 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0293 Weighted gene co-expression network analysis of DMARD-NAÏVE early ra patients achieving sustained drug-free remission after initiating tocilizumab therapy. (15th June 2017) Authors: Teitsma, XM; Jacobs, JW; Mokry, M; Pethö-Schramm, A; Borm, ME; Laar, JM van; Bijlsma, JW; Lafeber, FP Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0218 Effect of tocilizumab in DMARD-NAÏVE early rheumatoid arthritis patients on health-related quality of life: results of the U-ACT-EARLY trial. (15th June 2017) Authors: Teitsma, XM; Jacobs, JW; Welsing, PM; Pethö-Schramm, A; Borm, ME; Laar, JM van; Lafeber, FP; Bijlsma, JW Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 855 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0498 The performance of urinary collagen type II C-TELOPEPTIDE (UCTX-II) in knee osteoarthritis: a meta-analysis. (15th June 2017) Authors: Jeremiasse, B; Lafeber, FP; Spil, WE Van Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 963 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0499 Identification of biochemical phenotypes in knee osteoarthritis: longitudinal data from the fnih oa biomarker consortium. (15th June 2017) Authors: Jeremiasse, B; Welsing, PM; Fellows, C; Lafeber, FP; Spil, WE Van Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 964 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗